FDA Seeks Comments on Reducing Regulatory and Paperwork Burdens

The Food and Drug Administration is extending until Feb. 5, 2018, the period for comments on existing FDA regulations and related paperwork requirements that could be modified, repealed or replaced to reduce burdens on industry, it said. The effort is part of implementation of recent executive orders issued by President Donald Trump on reducing and reforming regulations, FDA said. The agency issued notices in September seeking comments on regulations and paperwork requirements related to biologics, medical devices, drugs, foods, tobacco products and veterinary medicines, as well as regulations and paperwork requirements that may cut across several of its product-based centers (see 1709070029).